Fact Sheet: President Donald J. Trump Announces Deal with Regeneron to Bring Most-Favored-Nation Pricing to American Patients

Fact sheetPublished 04/23Open the original

Summary

President Trump announces a 17th most-favored-nation pricing deal, with Regeneron: the TrumpRx price of the cholesterol drug Praluent falls from $537 to $225, and Regeneron will invest $27 billion in U.S. research, development and manufacturing by 2029.

By industry

Healthcare & Drug Pricing1 trading day+1.5%p15 stocks5 trading days+1.1%p15 stocks20 trading days−1.4%p15 stocks
“announced the 17th agreement with a major pharmaceutical manufacturer, Regeneron”

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
26/04/22	0.0%	0.0%
26/04/23	+1.3%	−0.2%
26/04/24	+0.0%	+0.5%
26/04/27	−0.1%	+0.8%
26/04/28	+0.9%	+0.3%
26/04/29	+1.4%	+0.3%
26/04/30	+2.4%	+1.4%
26/05/01	+1.4%	+1.3%
26/05/04	+1.3%	+1.1%
26/05/05	+1.1%	+2.3%
26/05/06	+0.3%	+3.2%
26/05/07	−0.1%	+2.9%
26/05/08	−0.2%	+3.9%
26/05/11	+0.2%	+4.1%
26/05/12	+2.1%	+3.8%
26/05/13	+3.0%	+4.6%
26/05/14	+3.1%	+5.3%
26/05/15	+1.8%	+3.8%
26/05/18	+2.3%	+4.1%
26/05/19	+3.3%	+3.3%
26/05/20	+2.6%	+4.0%

Stocks it names

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

Alan ArmstrongSenator · Republican · OK
BuyUnitedhealth Group
Buy
Unitedhealth Group
UNH
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
Full saleAmgen
Full sale
Amgen
AMGN
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
Full salePfizer
Full sale
Pfizer
PFE
$50K–$100K
Self
$50K–$100K
Reported 07/21
Traded 03/24
Lilly EndowmentOther
SellELI Lilly
Sell
ELI Lilly
LLY
$13.6M
13,620 sh
$13.6M
Filed 05/07
Traded 05/06
Alan ArmstrongSenator · Republican · OK
Full saleMerck
Full sale
Merck
MRK
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyAbbVie
Buy
AbbVie
ABBV
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyJohnson & Johnson
Buy
Johnson & Johnson
JNJ
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$187.3M
1,983,387 sh
$187.3M
Filed 05/21
Traded 05/19
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$74.6M
797,628 sh
$74.6M
Filed 05/21
Traded 05/20
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$34.6M
370,462 sh
$34.6M
Filed 05/21
Traded 05/21
Alan ArmstrongSenator · Republican · OK
BuyElevance Health
Buy
Elevance Health
ELV
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyMcKesson
Buy
McKesson
MCK
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
Full saleELI Lilly
Full sale
ELI Lilly
LLY
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyGilead Sciences
Buy
Gilead Sciences
GILD
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
Alan ArmstrongSenator · Republican · OK
BuyJohnson & Johnson
Buy
Johnson & Johnson
JNJ
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/30
Patrick Hugh ConwayCEO, Optum
SellUnitedhealth Group
Sell
Unitedhealth Group
UNH
$284K
800 sh
$284K
Filed 04/27
Traded 04/23
Lilly EndowmentOther
SellELI Lilly
Sell
ELI Lilly
LLY
$2.2M
2,208 sh
$2.2M
Filed 05/07
Traded 05/06
David V. ElkinsEVP, CFO
SellBristol Myers Squibb
Sell
Bristol Myers Squibb
BMY
$1.6M
25,519 sh
$1.6M
Filed 04/02
Traded 04/01
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$14.5M
152,691 sh
$14.5M
Filed 05/21
Traded 05/20
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$1.4M
10,000 sh
$1.4M
Filed 03/30
Traded 03/27